D. V. Lukyantseva

Improving cost assessment and health economic evaluation of a new medical technology during clinical approbation: the role of a structured costing tool

Objective. To improve cost assessment and health economic evaluation of a new medical technology during clinical approbation. Material and methods. We reviewed the scientific literature on the implementation of clinical approbation (CA) published between 2015 and 2025 and conduct...